Skip to main content

Table 4 Causes of death

From: Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

 

No-ATG

ATG

N = 144

N = 35

Relapse

77 (53.5%)

19 (54.3%)

GVHD

32 (22.2%)

6 (17.1%)

Infection

23 (16%)

5 (14.3%)

VOD

5 (3.5%)

3 (8.6%)

Idiopathic pneumonia

2 (1.4%)

0 (0%)

Hemorrhage

2 (1.4%)

0 (0%)

Other SCT-related

3 (2.1%)

2 (5.7%)

  1. ATG anti-thymocyte globulin, GVHD graft-versus-host disease, SCT stem cell transplantation, VOD veno-occlusive disease